Vir Biotechnology, Inc. - Common Stock (VIR)

Historical Holders from Q4 2019 to Q3 2025

Symbol
VIR on Nasdaq
CUSIP
92764N102
Type / Class
Equity / Common Stock
Shares outstanding
137M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
107M
Holdings value
$611M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
206
Number of buys
85
Number of sells
-104
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vir Biotechnology, Inc. - Common Stock (VIR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 10.8% $82M 14.8M BlackRock, Inc. Mar 31, 2025

Institutional Holders of Vir Biotechnology, Inc. - Common Stock (VIR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 107M $611M -$20.2M $5.71 206
2025 Q2 111M $559M +$84.6M $5.04 211
2025 Q1 93.3M $605M +$27.9M $6.48 230
2024 Q4 88.7M $651M +$14.5M $7.34 202
2024 Q3 87.6M $656M -$4.69M $7.49 196
2024 Q2 88.1M $784M -$8.2M $8.90 214
2024 Q1 88.7M $898M +$5.73M $10.13 204
2023 Q4 62.8K $638K -$467K $10.18 2
2023 Q3 87.1M $816M -$231M $9.37 207
2023 Q2 90M $2.21B +$34.9M $24.53 218
2023 Q1 88.3M $2.06B +$54.1M $23.27 223
2022 Q4 86M $2.18B -$13.3M $25.31 215
2022 Q3 85.6M $1.65B -$5.28M $19.28 200
2022 Q2 85.8M $2.18B +$133M $25.47 196
2022 Q1 81M $2.08B +$26.6M $25.72 184
2021 Q4 78M $3.25B +$168M $41.87 197
2021 Q3 74.4M $3.24B -$19.3M $43.52 168
2021 Q2 74.1M $3.5B +$64.6M $47.28 156
2021 Q1 74.8M $3.83B -$96.8M $51.27 146
2020 Q4 76M $2.04B +$149M $26.78 128
2020 Q3 69.4M $2.38B +$549M $34.33 113
2020 Q2 53.5M $2.19B +$657M $40.97 107
2020 Q1 37.9M $1.3B -$4.03M $34.27 60
2019 Q4 36.6M $460M +$460M $12.57 38